Kirsten M. Timms

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Melinda L. Telli, Kirsten M. Timms, Julia Reid et al. · Clinical Cancer Research · 2016 · 1.2K citations · Full text

Medicine, Genetics, Oncology +17

The DNA sequence of the human X chromosome

Mark T. Ross, Darren Grafham, Alison J. Coffey et al. · Nature · 2005 · 1.2K citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Andrew Tutt, Holly Tovey, Maggie C.U. Cheang et al. · Nature Medicine · 2018 · 903 citations · Full text

Medicine, Oncology, Pharmacology +11

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

Victor Abkevich, Kirsten M. Timms, Bryan T. Hennessy et al. · British Journal of Cancer · 2012 · 852 citations · Full text

Life Sciences, Genetics, Oncology +16

Incidence and Outcome of <i>BRCA</i> Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

Ana M. González-Angulo, Kirsten M. Timms, Shuying Liu et al. · Clinical Cancer Research · 2011 · 604 citations · Full text

Medicine, Genetics, Oncology +17